Breaking News: Embargoed Feed - hidden

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 3-Jun-2020 11:00 AM EDT Released to reporters: 1-Jun-2020 12:15 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

28-May-2020 9:00 AM EDT
Playing Video Games Linked with Unhealthy Behaviors for College Men
American Society for Nutrition (ASN)

Results from a new study suggest that college men who play video games tend to exercise less and have poorer eating habits compared to non-gamers.

28-May-2020 9:00 AM EDT
Researchers Identify Seasonal Peaks for Foodborne Infections
American Society for Nutrition (ASN)

Using a newly developed approach, researchers have identified seasonal peaks for foodborne infections that could be used to optimize the timing and location of food inspections.

28-May-2020 9:00 AM EDT
Eating Whole Grains Could Help Lower Diabetes Risk
American Society for Nutrition (ASN)

A new analysis of more than 200,000 people found that eating high-quality carbohydrates, such as whole grains, was associated with a lower risk for type 2 diabetes.

28-May-2020 9:00 AM EDT
Do Warning Labels Help People Choose Healthier Drinks?
American Society for Nutrition (ASN)

Warning labels on sugary drinks lead to healthier drink choices, according to new analysis of more than 20 studies examining these warnings.

28-May-2020 9:00 AM EDT
Study Pinpoints Top Sources of Empty Calories for Children and Teens
American Society for Nutrition (ASN)

A new study of children and teens found that more than 25% of the calories they consume were considered empty.

28-May-2020 9:00 AM EDT
Dieting? Studies Weigh In on Opportunities and Risks
American Society for Nutrition (ASN)

Get the latest research findings on fad diets, losing weight and healthful eating at NUTRITION 2020 LIVE ONLINE, a virtual conference featuring leading nutrition experts from around the world.

Newswise:Video Embedded sea-snail-human-insulin-hybrid-could-lead-to-better-diabetes-treatments
VIDEO
28-May-2020 9:00 AM EDT
Sea Snail, Human Insulin Hybrid Could Lead to Better Diabetes Treatments
University of Utah Health

Nearly a century after insulin was discovered, an international team of researchers including University of Utah Health scientists report that they have developed the world’s smallest, fully functional version of the hormone, one that combines the potency of human insulin with the fast-acting potential of a venom insulin produced by predatory cone snails. The finding, based on animal studies, could jumpstart the development of insulin treatments capable of improving the lives of those with diabetes.

28-May-2020 1:05 PM EDT
People with Type 1 Diabetes Spend About $2,500 a Year in Health Care Costs
Michigan Medicine - University of Michigan

Adults and children with type 1 diabetes will spend an average of $2,500 a year out-of-pocket for health care - but insulin isn't always the biggest expense - new research suggests

28-May-2020 5:40 PM EDT
Study in Chinese doctors shows mental toll of caring in the time of COVID-19
Michigan Medicine - University of Michigan

They worked in hospitals hundreds of miles from the epicenter of COVID-19. But hundreds of young Chinese doctors in a new study still experienced a sharp drop in mood, a rise in depression and anxiety symptoms, and a doubling of their fear of workplace violence, in the first month of the coronavirus pandemic.

Newswise:Video Embedded now-complete-telescope-instrument-is-poised-to-begin-its-search-for-answers-about-dark-energy
VIDEO
29-May-2020 3:05 PM EDT
Now Complete, Telescope Instrument is Poised to Begin Its Search for Answers About Dark Energy
Lawrence Berkeley National Laboratory

Even as the Dark Energy Spectroscopic Instrument, or DESI, lies dormant within a telescope dome on a mountaintop in Arizona, due to the COVID-19 pandemic, the DESI project has moved forward in reaching the final formal approval milestone prior to startup.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Jun-2020 1:00 PM EDT Released to reporters: 1-Jun-2020 10:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Jun-2020 1:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 4-Jun-2020 9:00 AM EDT Released to reporters: 1-Jun-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Jun-2020 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

28-May-2020 9:00 AM EDT
Experts Debate Saturated Fat Consumption Guidelines for Americans
American Society for Nutrition (ASN)

Should public health guidelines recommend reducing saturated fat consumption as much as possible? Nutrition experts are tackling that controversial question head-on in a new series of papers outlining key points of agreement—and disagreement—in how to interpret the evidence and inform health guidelines.

28-May-2020 11:35 AM EDT
Lessening water quality problems caused by hurricane-related flooding
American Chemical Society (ACS)

June 1 is the start of hurricane season in the Atlantic, with flooding often the most damaging effect of tropical storms. Now, in ACS’ Environmental Science & Technology, researchers study water quality impacts of two recent hurricanes in North Carolina and suggest interventions to protect susceptible areas.

Newswise: Killing Coronavirus with UV Light
31-May-2020 11:05 PM EDT
Killing Coronavirus with UV Light
Penn State Materials Research Institute

A personal, handheld device emitting high intensity ultraviolet light to disinfect areas by killing the Corona virus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.

Newswise: Editorial: Pandemic Puts Spotlight on Front-line Clinicians
28-May-2020 3:00 PM EDT
Editorial: Pandemic Puts Spotlight on Front-line Clinicians
American Association of Critical-Care Nurses (AACN)

In “A Tribute to Frontline Health Care Professionals During the COVID-19 Pandemic,” Annette Bourgault, editor of Critical Care Nurse, offers her personal and professional appreciation for the dedicated clinicians in acute and critical care.

Newswise: Disorder in fish shoals may reap rewards at dinner time
29-May-2020 8:10 AM EDT
Disorder in fish shoals may reap rewards at dinner time
University of Bristol

The advantages of animals foraging in an orderly group are well-known, but research by the University of Bristol has found an element of unruly adventure can help fish in the quest for food.

Newswise:Video Embedded parents-likely-have-inaccurate-view-of-children-s-digital-screentime
VIDEO
27-May-2020 1:15 PM EDT
Parents Likely Have Inaccurate View of Children’s Digital Screentime
Michigan Medicine - University of Michigan

Parents likely misjudge how much time their young children are plugged into mobile devices – or how they are spending that time – a new study suggests.

Newswise: New Therapeutic Possibilities on the Horizon—Targeted Protein Destruction Made Better
29-May-2020 9:00 AM EDT
New Therapeutic Possibilities on the Horizon—Targeted Protein Destruction Made Better
Tokyo University of Science

Scientists open doors to new treatment possibilities by using a metal complex to accelerate serum albumin protein destruction with infrared laser beams

access_time Embargo lifts in 2 days
Embargo will expire: 4-Jun-2020 5:00 PM EDT Released to reporters: 29-May-2020 6:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Jun-2020 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study reveals factors influencing outcomes in advanced kidney cancer treated with immunotherapy
28-May-2020 11:05 AM EDT
Study reveals factors influencing outcomes in advanced kidney cancer treated with immunotherapy
Dana-Farber Cancer Institute

By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.

27-May-2020 1:05 PM EDT
Electronic Health Records Fail to Detect Up to 33% of Medication Errors
University of Utah Health

Despite improvements in their performance over the past decade, electronic health records (EHRs) commonly used in hospitals nationwide fail to detect up to one in three potentially harmful drug interactions and other medication errors, according to scientists at University of Utah Health, Harvard University, and Brigham and Women’s Hospital in Boston.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 6:00 AM EDT Released to reporters: 29-May-2020 10:45 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 6:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 11:00 AM EDT Released to reporters: 29-May-2020 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 3-Jun-2020 9:00 AM EDT Released to reporters: 29-May-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jun-2020 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

27-May-2020 9:25 AM EDT
Nilotinib Appears Safe and Affects Biomarkers In Alzheimer’s Disease Clinical Trial
Georgetown University Medical Center

A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.

22-May-2020 12:25 PM EDT
Inequities in Access to Kidney Transplantation Exist Even with Universal Healthcare
American Society of Nephrology (ASN)

• In a study of patients with newly diagnosed kidney failure at 71 kidney centers in the UK, older age, additional illnesses, obesity, and lower socioeconomic status were associated with a lower likelihood of being put on transplant waiting list.

Newswise: Study Shows Profound Benefit with Targeted Therapy for Patients with Early Stage NSCLC
28-May-2020 5:00 PM EDT
Study Shows Profound Benefit with Targeted Therapy for Patients with Early Stage NSCLC
Yale Cancer Center

According to findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery significantly improves disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 6:00 AM EDT Released to reporters: 28-May-2020 3:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 6:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Plasma science report co-chaired by UAH astrophysicist urges better federal agency coordination
28-May-2020 1:45 PM EDT
Plasma science report co-chaired by UAH astrophysicist urges better federal agency coordination
University of Alabama Huntsville

Federal agencies should better coordinate their activities in plasma science and engineering (PSE) and jointly support new funding opportunities that take advantage of PSE’s overlaps with different science disciplines, according to a decadal report by the National Academy of Sciences (NAS).

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 11:00 AM EDT Released to reporters: 28-May-2020 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded global-environmental-changes-leading-to-shorter-younger-trees
VIDEO
24-May-2020 10:00 PM EDT
Global Environmental Changes Leading to Shorter, Younger Trees
Pacific Northwest National Laboratory

Ongoing environmental changes are transforming forests worldwide, resulting in shorter and younger trees. Researchers found that a range of factors, including rising temperatures and carbon dioxide levels, have caused a dramatic decrease in the age and stature of forests.

access_time Embargo lifts in 2 days
Embargo will expire: 3-Jun-2020 2:00 PM EDT Released to reporters: 28-May-2020 1:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jun-2020 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 11:00 AM EDT Released to reporters: 28-May-2020 11:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Material and Genetic Resemblance in the Bronze Age Southern Levant
28-May-2020 6:55 AM EDT
Material and Genetic Resemblance in the Bronze Age Southern Levant
University of Vienna

Different "Canaanite" people from the Bronze Age Southern Levant not only culturally, but also genetically resemble each other more than other populations. A team around Ron Pinhasi from the Department of Evolutionary Anthropology found in a recent study that their DNA is a mixture of two populations: The Chalcolithic Zagros and Early Bronze Age Caucasus. The results have been published in "Cell".

25-May-2020 8:55 AM EDT
Alcohol Use in Early Adolescence may Alter Reward Motivation
Research Society on Alcoholism

The brain responds to rewarding stimuli by increasing the release of a neurotransmitter called dopamine. When we feel motivated, it is because our brain anticipates this dopamine reward. The transition from early to mid-adolescence is associated with increased reward sensitivity and reward-seeking behavior, a consequence of normal brain development. This heightened sensitivity or prioritization of reward can be thought of as reflecting a greater motivation to obtain rewards. A new study, published in Alcoholism: Clinical and Experimental Research, has addressed whether drinking alcohol in early adolescence might impact the brain’s reward systems, by examining associations between alcohol initiation and subsequent changes in reward motivation while accounting for baseline scores. Differences between boys and girls were also evaluated.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 2:30 PM EDT Released to reporters: 28-May-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 2:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project
28-May-2020 8:00 AM EDT
Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project
Massachusetts Eye and Ear

The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham. AAVCOVID is a unique gene-based vaccine candidate designed to protect against SARS-CoV-2, the virus that causes COVID-19.

28-May-2020 8:00 AM EDT
AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
Massachusetts Eye and Ear

AveXis, will lead the manufacturing efforts of the new AAVCOVID vaccine, utilizing its cutting-edge AAV technology for treatment of rare and life-threatening neurological genetic diseases. AveXis has the option to manufacture the AAV vaccine for additional clinical development, registration and/or commercial activities.

28-May-2020 8:00 AM EDT
AAVCOVID Vaccine Program Expands Manufacturing Agreements with Gene Therapy Industry Partners Viralgen, Aldevron, and Catalent
Massachusetts Eye and Ear

The AAVCOVID vaccine program at Massachusetts Eye and Ear and Massachusetts General Hospital has entered into manufacturing agreements with Viralgen, Aldevron and Catalent in order to support manufacturing of the experimental vaccine for clinical studies in the second half of 2020.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 11:00 AM EDT Released to reporters: 28-May-2020 4:45 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

22-May-2020 3:05 PM EDT
Biomarkers May Help Us Understand Recovery Time After Concussion
American Academy of Neurology (AAN)

A blood test may help researchers understand which people may take years to recover from concussion, according to a study published in the May 27, 2020 online issue of Neurology®, the medical journal of the American Academy of Neurology. The study looked at a biomarker called neurofilament light chain, a nerve protein that can be detected in the blood when nerve cells are injured or die.

Newswise: iX0OVC4Z6dvBBJS7iKIQmpro1OPwuVvs_93Jqp5Y8Q_YNZi7vi4rIUUt96eE4luAxERxuoQ5YOcI8yDb51NuyGAuHMf90l6wxvu4NbmvVOxHKx3P717rJcalzzFeOrHU07epzpEsRR96lKxhZIBWQrJCwdosVBAm1ivQtBOORbkomBrWYRvqHQJqKL6bGiVMYIQPn-7Q_-yRyCJiSP4=s0-
21-May-2020 10:50 AM EDT
In stressed ecosystems Jurassic dinosaurs turned to scavenging, maybe even cannibalism
PLOS

Among dinosaurs of ancient Colorado, scavenging and possibly cannibalism were responses to a resource-scarce environment, according to a study published May 27, 2020 in the open-access journal PLOS ONE by Stephanie Drumheller of the University of Tennessee, Knoxville, and colleagues.

22-May-2020 11:45 AM EDT
A few months of vaping puts healthy people on the brink of oral disease
Ohio State University

The collection of oral bacteria in daily e-cigarette users’ mouths is teeming with potent infection-causing organisms that put vapers at substantial risk for ailments ranging from gum disease to cancer, researchers found.

Newswise: ‘Nature’s antifreeze’ provides formula for more durable concrete
21-May-2020 8:00 AM EDT
‘Nature’s antifreeze’ provides formula for more durable concrete
University of Colorado Boulder

Secrets to cementing the sustainability of our future infrastructure may come from nature, such as proteins that keep plants and animals from freezing in extremely cold conditions. CU Boulder researchers have discovered that a synthetic molecule based on natural antifreeze proteins minimizes freeze-thaw damage and increases the strength and durability of concrete, improving the longevity of new infrastructure and decreasing carbon emissions over its lifetime.

22-May-2020 12:05 PM EDT
Follow-up Treatments After Opioid Overdose Rare Among Insured Patients
Perelman School of Medicine at the University of Pennsylvania

Of nearly 6,500 commercially insured patients treated in EDs nationwide for an overdose or other opioid-related medical complications, only 16 percent accessed opioid use disorder (OUD) medications or another form of treatment within three months of the ED visit.

Newswise: Treatment shows promise in treating deadly brain cancer
25-May-2020 8:55 AM EDT
Treatment shows promise in treating deadly brain cancer
McMaster University

In this study, researchers investigated if specific targeting of CD133+ glioblastoma with cutting-edge immunotherapy drugs could eradicate the most aggressive subpopulation of cells in the tumour. They also looked at the safety of CD133-targeting therapies on normal, non-cancerous human stem cells including hematopoietic stem cells which create blood cells and progenitor cells which can form one or more kinds of cells.

22-May-2020 9:30 AM EDT
Winds spread PFAS pollution far from a manufacturing facility
American Chemical Society (ACS)

Concerns about environmental and health risks of some fluorinated carbon compounds have prompted manufacturers to develop substitutes, but these replacements are increasingly coming under fire themselves. Scientists have been studying how widely these chemicals have contaminated the environment.


Showing results

150 of 23621

close
5.50505